deoxycytidine has been researched along with Hepatic Encephalopathy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, S; Akaboshi, S; Baba, H; Beppu, T; Eto, S; Furuhashi, S; Horino, K; Ida, S; Nakahara, O; Ozaki, N; Takamori, H; Tanaka, H | 1 |
Dobbie, M; Herrmann, R; Hofer, S; Oberholzer, M | 1 |
2 other study(ies) available for deoxycytidine and Hepatic Encephalopathy
Article | Year |
---|---|
[Acute liver injury with hepatic encephalopathy associated with gemcitabine administration for adjuvant chemotherapy in an HBV carrier with pancreatic cancer].
Topics: Acute Disease; Aged; Amino Acids, Branched-Chain; Chemotherapy, Adjuvant; Deoxycytidine; Female; Gemcitabine; Hepatic Encephalopathy; Hepatitis B; Humans; Lactulose; Liver; Pancreatic Neoplasms; Tomography, X-Ray Computed | 2010 |
Veno-occlusive disease of the liver induced by gemcitabine.
Topics: Antimetabolites, Antineoplastic; Budd-Chiari Syndrome; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Fatal Outcome; Female; Gemcitabine; Hepatic Encephalopathy; Humans; Lung Neoplasms; Middle Aged | 1998 |